Cerity Partners’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
8,543
+775
+10% +$101K ﹤0.01% 1861
2026
Q1
$1M Buy
7,768
+715
+10% +$103K ﹤0.01% 1862
2025
Q4
$1.01M Buy
7,053
+165
+2% +$22.1K ﹤0.01% 1723
2025
Q3
$826K Buy
6,888
+148
+2% +$18.8K ﹤0.01% 1693
2025
Q2
$891K Sell
6,740
-2,215
-25% -$300K ﹤0.01% 1571
2025
Q1
$1.24M Sell
8,955
-328
-4% -$50.9K ﹤0.01% 1328
2024
Q4
$1.64M Sell
9,283
-563
-6% -$95.2K ﹤0.01% 1194
2024
Q3
$1.79M Buy
9,846
+2,454
+33% +$363K ﹤0.01% 1139
2024
Q2
$878K Sell
7,392
-619
-8% -$65.1K ﹤0.01% 1285
2024
Q1
$860K Buy
+8,011
New +$797K ﹤0.01% 1348
2019
Q2
– Sell
-1,416
Closed -$339K – 530
2019
Q1
$339K Buy
1,416
+61
+5% +$14.6K 0.02% 397
2018
Q4
$311K Buy
1,355
+400
+42% +$98.6K 0.02% 396
2018
Q3
$270K Sell
955
-26
-3% -$7.62K 0.02% 442
2018
Q2
$288K Buy
+981
New +$268K 0.02% 429
2017
Q4
– Sell
-1,725
Closed -$321K – 574
2017
Q3
$321K Buy
+1,725
New +$301K 0.02% 419

Other funds holding ICUI

Cerity Partners's ICUI Position: Q2 2026 in Review

Cerity Partners increased its ICU Medical (ICUI) stake by 10% in Q2 2026, buying an estimated $101K and bringing the position to 8,543 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1861.

Cerity Partners first reported a position in ICUI in Q3 2017 and has held it in 15 quarters since. The position peaked at $1.79M in Q3 2024. 288 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

  • Cerity Partners held 8,543 shares of ICU Medical worth $1.25M as of Q2 2026.
  • Cerity Partners bought 775 ICU Medical shares in Q2 2026, an estimated $101K.
  • ICU Medical made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1861 holding.
  • Cerity Partners first reported a position in ICU Medical in Q3 2017 and has held it in 15 quarters since.
  • Cerity Partners's ICU Medical position peaked at $1.79M in Q3 2024.
  • 288 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.